Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Ronald Witteles's publication output changed over time?
ScholarIQpublication output · 2007–2024
Output grew0% over the shown period — from 1 works in 2007 to 1 in 2024.
1
1
2
1
3
2
1
2007200820162018201920202024
What are the most-cited papers on Ronald Witteles?
ScholarIQmost cited works
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Matthew J. Maurer, Jeffrey H. Schwartz, Balarama Gundapaneni, Perry Elliott, Giampaolo Merlini, Márcia Waddington‐Cruz, Arnt V. Kristen, Martha Grogan, Ronald Witteles, Thibaud Damy, Brian Drachman, Sanjiv J. Shah, Mazen Hanna, Daniel P. Judge, Alexandra I. Barsdorf, Peter M. Huber, Terrell A. Patterson, Steve Riley, Jennifer Schumacher, Michelle Stewart, Marla B. Sultan, Claudio Rapezzi
New England Journal of Medicine. 20182,771 CitationsOPEN ACCESS
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
Giuseppe Curigliano, Daniel J. Lenihan, Michael G. Fradley, Sarju Ganatra, Ana Barac, Anne Blaes, J. Herrmann, Charles Porter, Alexander R. Lyon, P Lancellotti, Aarti Patel, Jeanne M. DeCara, Joshua D. Mitchell, Eric Harrison, Javid J. Moslehi, Ronald Witteles, Maria Grazia Calabró, Roberto Orecchia, Evandro de Azambuja, J. L. Zamorano, Ronald J. Krone, Zaza Iakobishvili, Joseph R. Carver, Saro H. Armenian, Bonnie Ky, Daniela Cardinale, Carlo M. Cipolla, Susan Dent, Karin Jordan
Annals of Oncology. 20201,022 CitationsOPEN ACCESS
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
Alexander R. Lyon, Susan Dent, Susannah Stanway, Helena Earl, Christine Brezden‐Masley, Alain Cohen‐Solal, Carlo G. Tocchetti, Javid J. Moslehi, John D. Groarke, Jutta Bergler‐Klein, Vincent Khoo, Li Ling Tan, Markus S. Anker, Stephan von Haehling, Christoph Maack, Radek Pudil, Ana Barac, Paaladinesh Thavendiranathan, Bonnie Ky, Tomas G. Neilan, Yu. N. Belenkov, Stuart D. Rosen, Zaza Iakobishvili, Aaron L. Sverdlov, Ludhmila Abrahão Hajjar, Ariane Vieira Scarlatelli Macedo, Charlotte Manisty, Fortunato Ciardiello, Dimitrios Farmakis, Rudolf A. de Boer, Hadi Skouri, Thomas Suter, Daniela Cardinale, Ronald Witteles, Michael G. Fradley, Joerg Herrmann, Robert F. Cornell, Ashutosh Wechelaker, Michael J. Mauro, Dragana Milojković, Hugues de Lavallade, Frank Ruschitzka, Andrew J.S. Coats, Petar Seferović, Ovidiu Chioncel, Thomas Thum, Johann Bauersachs, María Sol Andrés, David J. Wright, Teresa López‐Fernández, Chris Plummer, Daniel J. Lenihan
European Journal of Heart Failure. 2020796 CitationsOPEN ACCESS
Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
Paul W. Burridge, Yong Fuga Li, Elena Matsa, Haodi Wu, Sang‐Ging Ong, Arun Sharma, Alexandra Holmström, Alex Chia Yu Chang, Michael Coronado, Antje Ebert, Joshua W. Knowles, Melinda L. Telli, Ronald Witteles, Helen M. Blau, Daniel Bernstein, Russ B. Altman, Joseph C. Wu
Nature Medicine. 2016765 Citations
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis
Mathew S. Maurer, Sabahat Bokhari, Thibaud Damy, Sharmila Dorbala, Brian Drachman, Marianna Fontana, Martha Grogan, Arnt V. Kristen, Isabelle Lousada, José Nativi-Nicolau, Candida Cristina Quarta, Claudio Rapezzi, Frederick L. Ruberg, Ronald Witteles, Giampaolo Merlini
Circulation Heart Failure. 2019559 CitationsOPEN ACCESS
Related on ScholarIQ
Alnylam Pharmaceuticals (United States)
Institution
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Paper
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
Paper
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
Paper
Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
Paper
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis
Paper